AMP, CME And BLK, Pushing Financial Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 3 points (0.0%) at 16,165 as of Thursday, Dec. 19, 2013, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,090 issues advancing vs. 1,843 declining with 148 unchanged.

The Financial Services industry currently sits down 0.2% versus the S&P 500, which is down 0.2%. On the negative front, top decliners within the industry include Nomura Holdings ( NMR), down 2.1%, American Capital ( ACAS), down 1.7%, KKR ( KKR), down 1.6%, Western Union Company ( WU), down 1.0% and Discover Financial Services ( DFS), down 0.9%. A company within the industry that increased today was TD Ameritrade Holding Corporation ( AMTD), up 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Ameriprise Financial ( AMP) is one of the companies pushing the Financial Services industry lower today. As of noon trading, Ameriprise Financial is down $0.61 (-0.6%) to $111.21 on light volume. Thus far, 302,032 shares of Ameriprise Financial exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $110.65-$111.50 after having opened the day at $111.43 as compared to the previous trading day's close of $111.82.

Ameriprise Financial, Inc., through its subsidiaries, provides a range of financial products and services in the United States and internationally. Ameriprise Financial has a market cap of $21.1 billion and is part of the financial sector. The company has a P/E ratio of 16.1, below the S&P 500 P/E ratio of 17.7. Shares are up 78.5% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Ameriprise Financial a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Ameriprise Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Ameriprise Financial Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, CME Group ( CME) is down $0.77 (-0.9%) to $83.87 on light volume. Thus far, 373,021 shares of CME Group exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $83.81-$84.70 after having opened the day at $84.16 as compared to the previous trading day's close of $84.64.

CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. CME Group has a market cap of $27.8 billion and is part of the financial sector. The company has a P/E ratio of 29.1, above the S&P 500 P/E ratio of 17.7. Shares are up 67.0% year to date as of the close of trading on Wednesday. Currently there are 7 analysts that rate CME Group a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full CME Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, BlackRock ( BLK) is down $2.15 (-0.7%) to $307.54 on light volume. Thus far, 159,067 shares of BlackRock exchanged hands as compared to its average daily volume of 619,400 shares. The stock has ranged in price between $306.12-$309.98 after having opened the day at $309.07 as compared to the previous trading day's close of $309.69.

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors. BlackRock has a market cap of $50.6 billion and is part of the financial sector. The company has a P/E ratio of 19.0, above the S&P 500 P/E ratio of 17.7. Shares are up 46.4% year to date as of the close of trading on Wednesday. Currently there are 5 analysts that rate BlackRock a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates BlackRock as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, reasonable valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full BlackRock Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the financial services industry could consider Financial Select Sector SPDR ( XLF) while those bearish on the financial services industry could consider Proshares Short Financials ( SEF).

null

More from Markets

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar